We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » OTC Manufacturers Warned for Claims, Misbranding Products
OTC Manufacturers Warned for Claims, Misbranding Products
July 5, 2011
Continuing recent efforts to closely monitor OTC product manufacturers, the FDA recently posted several warning letters sent to companies whose marketing claims would classify their products as drugs under agency regulations, or whose products contain undeclared active pharmaceutical ingredients.